There may not be much to say on the oncology company actually....

There may not be much to say on the oncology company actually. Maybe its better to wait until more details come out.

I will tidy up my previous comments around dilution though. i calculate dilution as:
- 30% to ACL
- 42% to Oncology Company

That assumes they raise 15m (7.5m IPO, 7.5m options) and i dont partake in the SPP. this needs to be validated once they tell us the details of the IPO though.

I was hoping for a 30% dilution but i can live with an average of 36%. I can buy a few more at these prices to reduce it further too. So not too bad.

Now we need to see great numbers from DRL and good news indicating that HA-Iri kills cancer stem cells. That will drive the share price for both fonda and oncology.